Efficacy and safety of intratracheal IFN-γ treatment to reverse stroke-induced susceptibility to pulmonary bacterial infections
April 14, 2021 10:31 amJagdmann S, Berchtold D, Gutbier B, Witzenrath M, Meisel A, Meisel C, Dames C: Efficacy and safety of intratracheal IFN-γ treatment to reverse stroke-induced susceptibility to pulmonary bacterial infections. Journal of Neuroimmunology, DOI: 10.1016/j.jneuroim.2021.577568 (2021).
Categorised in:
This post was written by redakteur